Clinical Trials
5 trialsNCT06868433 2026-03-04
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Emory University
Phase 1 Recruiting
NCT03800134 2025-06-11
AEGEAN
AstraZeneca
Phase 3 Active not recruiting
NCT05144100 2021-12-03
SCOPE
Tata Memorial Centre
Phase 2/3 Not yet recruiting
NCT01218048 2018-08-16
ERBITUX® Followed by Adjuvant Treatment With Chemoradiation and ERBITUX® for Locally Advanced Head and Neck Squamous Cell Carcinoma
University of Pittsburgh
Phase 2 Completed
NCT00191308 2011-10-21
Molecular Profiling in Lung Cancer Patients
Eli Lilly and Company
Phase 2 Completed